More interestingly, matrine was able to upregulate the expression of RIPK3 in Mz-ChA-1 cells, making it possible to treat cholangiocarcinoma with a low expression of RIPK3 [344]. The gene discussed is RIPK3; the disease is cholangiocarcinoma.